| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC2047 |
| Trial ID | NCT03811457 |
| Disease | Lymphoid Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Welgenaleucel|UWC19 |
| Recruitment status | Completed |
| Title | Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | UWELL Biopharma |
| Other ID(s) | UCAR019 |
| Cohort 1 | |||||||||
|
|||||||||